DP2

Dược phẩm Trung ương 2 ·UPCOM ·2026Q1

▼▼ Declining sharply

Margins remain under pressure Net margin −7.35%, −3.67pp YoY
Price
4,000
Latest close
29 May 2026
P/E -5.83x
P/B 1.26x
EPS -687
BVPS 3,164
ROE -19.5%
ROA -3.3%
Profit Margin -7.3%
Asset Turnover 0.44x
Equity Mult. 5.99x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DP2 posted a very sharp profit drop versus the same period, showing that pressure has clearly fed through to the bottom line. More notably, profit relies heavily on non-core sources while operating cash flow is negative — these two factors together suggest earnings quality needs cautious evaluation.

TTM REVENUE
VND 187bn
−5.1%YoY
NET MARGIN
−7.35%
−3.7ppYoY
TTM NET PROFIT
−VND 14bn
−89.6%YoY
Net financial result / PBT
95.5%
affects earnings quality
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 29.4 45.0 49.9 62.7 41.5 51.8 43.8 59.7 44.9 44.5 37.6 56.1
Growth -35% -10% -20% +51% -20% +18% -27% +33% +1% +18% -33%
Net Income -6.9 -4.9 -2.4 0.5 -3.5 2.4 -5.8 -0.3 -1.4 -10.1 -4.6 -6.1
Net Margin -23.46% -10.92% -4.81% 0.74% -8.32% 4.55% -13.28% -0.55% -3.11% -22.78% -12.11% -10.78%

Drivers of DP2's profit

TTM

Net profit attributable to parent declined vs last year, mainly due to higher finance costs. Supporting and offsetting drivers:

Gross profit ↑ 5.2bn
Finance costs ↑ 8.0bn
Other profit ↓ 3.5bn
Administrative expenses ↑ 0.7bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:

Gross profit ↓ 2.8bn
Administrative expenses ↑ 0.4bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 -8.9% = -3.7% × 0.44 × 5.52
2026Q1 -19.5% = -7.3% × 0.44 × 5.99

ROE fell from -8.9% to -19.5% — net margin weakened the most, though asset turnover and leverage still provided support.

Net margin: -7.3% -3.7pp Asset turnover: 0.44x +0.00x Leverage: 5.99x +0.47x

Is the profit sustainable?

Margins are under pressure while earnings still rely significantly on non-core sources.

very positive positive stable watch under pressure

What is driving the margin?

Net margin fell to -7.35%, losing 3.7pp. The main pressure is SG&A / Revenue rose 0.7pp, outweighing the improvement in Gross margin rose 3.3pp (with lingering pressure from Net financial result / Revenue fell 4.4pp and Other profit / Revenue fell 1.9pp).

The pressure comes from non-core items while core operations hold their rhythm — margin has a basis to recover once this factor passes.

Profitability trend

Net Margin -7.35% −3.7pp
Gross Margin 11.81% +3.3pp
SG&A / Revenue 9.99% +0.7pp
Non-core / Revenue -9.17% −6.3pp

TTM YoY · 2025Q1 -> 2026Q1

Watchpoints

Financial result share remains high

Even though contribution decreased by 6.3pp, financial result still accounts for 124.7% of PBT — earnings durability should be monitored in coming periods.

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC
NOPAT Margin
Capital Turnover 1.65x +0.57x
Average Invested Capital 113.5bn −69.5bn

Balance Sheet

ROIC above should be read with industry context — the balance sheet below adds perspective. Leverage is very high, with clear pressure on the capital structure — liabilities at 4.85x equity, with a net cash position equivalent to 0.03x equity.

Inventory ended the period at 41.6bn, roughly 10.1% of total assets.

Over the last 12 months, working capital released 0.0bn of cash.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables were broadly stable → neutral CFO:
Inventories were broadly stable → neutral CFO:
Payables were broadly stable → neutral CFO:

Working Capital Efficiency

Cash conversion cycle lengthened by 24.3 days versus the same period last year. The main moves came from DIO rose 15.3 days, DSO fell 2.8 days, and DPO fell 11.8 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 112.4 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Inventory turnover is slowing

DIO increased by +15.3 days, suggesting more capital is being tied up in inventories.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 46.0 days −2.8 days
Inventory 112.3 days +15.3 days
Payables 46.0 days −11.8 days
Cash Conversion Cycle 112.4 days +24.3 days

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 21.7bn.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at -0.03x and interest coverage only at -0.74x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 113.8% of debt, and total debt stands at 95.1bn.

Watchpoints

Interest coverage is thin

Interest coverage is -0.74x, leaving limited room to absorb financing costs.

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity -0.03x −1.31x
Interest Coverage -0.74x +0.54x
Cash / Debt 113.8% +111.1pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI -1.39x −2.37x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 21.7bn in 2025, against investing cash flow of -0.6bn.

Post-investment cash flow was positive +21.0bn. Financing cash flow was negative +4.7bn.

CFO / net income was -1.39x.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 19.1bn +26.2bn
Cash Capex
FCF TTM

Investment Takeaway

The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. Even so, earnings quality still needs closer monitoring because net financial result remains elevated. The main risk still sits in core profitability, with net margin down 3.7 pp.

Watchpoint: the earnings mix still needs monitoring, with net financial result still accounting for 95.5% of PBT and CFO / net income currently at -1.39x.

Key risk: profitability remains under pressure, with trailing-12M net margin at -7.35% after a 3.7pp decline versus the same period last year.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
199.0 200.2 193.2 188.2 180.0
Cost of Goods Sold
174.2 182.4 182.9 180.9 0.0
Gross Profit
24.8 17.7 10.3 7.3 7.9
Financial Expenses
13.2 5.2 15.8 14.9 -12.1
Selling Expenses
3.5 3.9 4.3 3.8 -2.9
General and Administrative Expenses
15.2 14.7 13.5 13.2 -11.5
Operating Profit
-6.9 -6.1 -23.3 -21.0 -18.5
Profit Before Tax
-10.8 -5.6 -24.0 -23.8 -17.9
Net Income
-10.8 -5.6 -24.0 -23.8 -17.9
Profit Attributable to Parent
-10.8 -5.6 -24.0 -23.8 -17.9
Earnings per Share
-541.00 -278.00 -1,202.00 -1,188.00 -896.19

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.